Please login to the form below

Not currently logged in
Email:
Password:

New hires for Wave

Med ed agency adds three new team members
Wave, Charlotte WilkinsonWave, James KeaneWave, Philippa Hatch

Charlotte Wilkinson, James Keane, Philippa Hatch

UK-based medical education company Wave has appointed three new members of staff.

Charlotte Wilkinson (top left) joins as programme manager and James Keane (top centre) and Philippa Hatch (top right) as senior programme executives.

Wilkinson comes from a background of managing communication programmes in the healthcare sector and for the Royal Society of Chemistry.

Hatch has experience in both programme management and business development within healthcare communication agencies. Keane joins Wave from a publishing background, having worked as a production editor on a number of scientific journals.

“We are delighted that Charlotte, Philippa and James have joined us as they each complement the skills base we have within Wave,” said Wave co-owner and director Rod Ball.

“These appointments reflect the continuing growth of our business as we expand our European and international work”.

Founded in April 2001, Amersham-based Wave partners with market access, patient programme and PR specialists to provide integrated communications.

The agency works with pharma companies, providing services ranging from advocacy management to NHS policy and local initiatives.

28th May 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics